Do you want to read an article? Please log in or register.
Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis
J Crohns Colitis
D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S
doi: 10.1093/ecco-jcc/jjaf080
Inflammatory Bowel Disease
Biologic switch timing and risk of infection in patients with ulcerative colitis/Crohn's disease: a retrospective study
Clin Gastroenterol Hepatol
Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF
doi: 10.1016/j.cgh.2025.01.028
RECOMMENDED
Inflammatory Bowel Disease
Fruits, vegetables, legumes and potatoes and risk of Crohn's disease and ulcerative colitis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Meyer A, Carbonnel F, Dahm CC, Halkjær J, Tjønneland A, Schulze MB, Sacerdote C, Tumino R, Oldenburg B, Huerta JM, Guevara M, Aune D, Gunter MJ, Heath AK, Vineis P, Tong TYN, Amiot A, Chan SSM
doi: 10.14309/ajg.0000000000003602
Inflammatory Bowel Disease
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn's Disease and Ulcerative Colitis: 2-Year Results from Open-Label Extensions of Two Randomized Controlled Trials (LIBERTY)
J Crohns Colitis
Colombel JF, Sandborn WJ, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Kim JM, Park G, Lee J, Lee J, Ryu JY, Sands BE, Hanauer SB
doi: 10.1093/ecco-jcc/jjaf060
Inflammatory Bowel Disease
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease
Insights Imaging
Sakai NS, Plumb AA, Ahmed N, Chowdhury K, Kilic Y, Hameed M, Patel A, Bhagwanani A, Helbren E, Hyland R, Bhatnagar G, Sidhu H, Lambie H, Franklin JM, Mohsin M, Thomson E, Boone D, Tolan D, Rahman S, Ding N, Moran GW, Bloom S, Hart A, Menys A, Travis S, Halligan S, Taylor SA, Motility trial investigators
doi: 10.1186/s13244-025-01930-w
Inflammatory Bowel Disease
Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study
Clin Gastroenterol Hepatol
Louis E, Sebastian S, Siegmund B, Bossuyt P, Danese S, de Boer N, Loftus EV, Moum B, Peyrin-Biroulet L, Schreiber S, Zhou J, Angellotti E, Adsul S, Jones S, Siegel CA
doi: 10.1016/j.cgh.2025.10.006
RECOMMENDED
Inflammatory Bowel Disease
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Fiorino G, Fidalgo C, Adamina M, Barreiro-de Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, Jӓghult S, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Yanai H, Zagórowicz E, Walsh A, European Crohn’s Colitis Organisation
doi: 10.1093/ecco-jcc/jjaf105
Inflammatory Bowel Disease
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial
Inflamm Bowel Dis
Ahuja D, Anvari S, Wong ECL, Dulai P, Marshall JK, Jairath V, Reinisch W, Narula N
doi: 10.1093/ibd/izaf137
Inflammatory Bowel Disease
Inflammatory Bowel Disease therapies and Demyelinating Diseases: A Practical Guide to Therapeutic Benefit and Risk
J Crohns Colitis
Honap S, Debouverie M, Filippi M, Selchen D, Jairath V, Danese S, Peyrin-Biroulet L
doi: 10.1093/ecco-jcc/jjaf215